Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix Molecular Dx Gets New Facility in Toronto

NEW YORK, April 10 (GenomeWeb News) - CombiMatrix Molecular Diagnostics has established a new facility in Toronto, the company, a subsidiary of CombiMatrix, said today.

 

The new facility is located at the MaRS (Medical and Related Sciences) Discovery District, a not-for-profit corporation, in downtown Toronto, and will be led by Mansoor Mohammed, CMDX's chief scientific officer and vice president, who is a Canadian citizen.

 

"Moving forward we anticipate establishing strong relationships with Canadian customers, partners, and the government," said CombiMatrix CEO Amit Kumar in a company statement.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.